Clinical interventions in aging · 2021
Incidence, Predictors and Outcomes of Delirium in Complicated Type B Aortic Dissection Patients After Thoracic Endovascular Aortic Repair.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Jitao, Yang Fan, Luo Songyuan, Li Chenxi, Liu Weijie, Liu Yuan, Huang Wenhui, Xie Enmin, Chen Lyufan, Su Sheng, Yang Xinyue, Geng Qingshan, Luo Jianfang
Аннотация
PURPOSE: The present study aimed to investigate the incidence and predictors of post-operative delirium (POD) in patients with complicated type B aortic dissection (TBAD) undergoing TEVAR with/without concomitant procedures and to assess the association of POD with early and follow-up outcomes.
METHODS: A retrospective single-center cross-sectional analysis was conducted using a prospectively maintained database from 2010 to 2017. Outcomes were postoperative clinical outcomes, early and follow-up survival.
RESULTS: A total of 517 complicated TBAD patients were enrolled. POD was observed in 13.3% (69/517) patients and was associated with increased hospital length of stay (LOS) and hospital costs (P< 0.001 for both). Besides, POD was found to be an independent risk factor for prolonged ICU stay (odds ratio [OR] 4.39, 95% confidence interval [CI] 2.40-8.01, P< 0.001) and early death (OR 4.42, 95% CI 1.26-15.54, P= 0.020). Predictors of POD were hybrid procedure (OR 2.17, 95% CI 1.20-3.92, P= 0.010), the use of benzodiazepine (OR 1.86, 95% CI 1.07-3.23, P= 0.027) or quinolone (OR 2.35, 95% CI 1.26-4.38, P= 0.007), creatinine >2 mg/dL (OR 3.25, 95% CI 1.57-6.72, P= 0.001) and preoperative blood transfusion (OR 3.31, 95% CI 1.76-6.21, P< 0.001). After a median follow-up of 73.6 months, POD remained as an independent indicator for follow-up mortality (hazard ratio [HR] 2.40, 95% CI 1.31-4.38, P= 0.005) after adjusting potential confounders.
CONCLUSION: POD after TEVAR has an incidence of around 13% and could profoundly increase the in-hospital LOS, hospital costs, as well as the early and follow-up mortality. A series of risk factors, including hybrid procedure, the use of benzodiazepine or quinolone, creatinine >2 mg/dL and preoperative blood transfusion, were identified as independent risk factors for POD. Effective risk-stratification and patient-tailored management strategy should be developed to reduce the incidence of POD.
METHODS: A retrospective single-center cross-sectional analysis was conducted using a prospectively maintained database from 2010 to 2017. Outcomes were postoperative clinical outcomes, early and follow-up survival.
RESULTS: A total of 517 complicated TBAD patients were enrolled. POD was observed in 13.3% (69/517) patients and was associated with increased hospital length of stay (LOS) and hospital costs (P< 0.001 for both). Besides, POD was found to be an independent risk factor for prolonged ICU stay (odds ratio [OR] 4.39, 95% confidence interval [CI] 2.40-8.01, P< 0.001) and early death (OR 4.42, 95% CI 1.26-15.54, P= 0.020). Predictors of POD were hybrid procedure (OR 2.17, 95% CI 1.20-3.92, P= 0.010), the use of benzodiazepine (OR 1.86, 95% CI 1.07-3.23, P= 0.027) or quinolone (OR 2.35, 95% CI 1.26-4.38, P= 0.007), creatinine >2 mg/dL (OR 3.25, 95% CI 1.57-6.72, P= 0.001) and preoperative blood transfusion (OR 3.31, 95% CI 1.76-6.21, P< 0.001). After a median follow-up of 73.6 months, POD remained as an independent indicator for follow-up mortality (hazard ratio [HR] 2.40, 95% CI 1.31-4.38, P= 0.005) after adjusting potential confounders.
CONCLUSION: POD after TEVAR has an incidence of around 13% and could profoundly increase the in-hospital LOS, hospital costs, as well as the early and follow-up mortality. A series of risk factors, including hybrid procedure, the use of benzodiazepine or quinolone, creatinine >2 mg/dL and preoperative blood transfusion, were identified as independent risk factors for POD. Effective risk-stratification and patient-tailored management strategy should be developed to reduce the incidence of POD.